Sanjeev Kumar, MD
Pain Medicine · Gainesville, FLNPI 1245407279
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,180 of the $1,408 with a category attached, or 83.8%. 6 manufacturers reported payments, led by Relievant Medsystems, Inc. at 51.4% of the total. That places this record below the midpoint for pain medicine clinicians in FL, where the typical reported total is $2,085.
Across 8 payments — averaging $176.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Relievant Medsystems, Inc.$724
- Surgentec$292
- Elliquence, LLC$164
- Abbott$99
- Boston Scientific$92
- Organogenesis Inc.$37
Across 12 payments — averaging $961.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Nevro Corp.$12K
What the payments were for
- Travel & lodging$1,18084%
- Food & beverage$22816%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Relievant Medsystems, Inc. | 2 | $724 |
| Surgentec | 1 | $292 |
| Elliquence, LLC | 1 | $164 |
| Abbott | 1 | $99 |
| Boston Scientific | 2 | $92 |
| Organogenesis Inc. | 1 | $37 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,408 in reported general payments places this provider in the 40th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 48 | $891 |
| Duloxetine Hcl | 25 | $427 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $418 |
| Gabapentin | 35 | $328 |
| Morphine Sulfate ErMorphine Sulfate | 11 | $133 |
| Tramadol Hcl | 20 | $106 |
| Meloxicam | 14 | $50 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Gainesville
- Timothy FeldheimGainesville$29K
- Jason WeiGainesville$17K
- Jeffrey GudinMiami$356K
- Joseph PergolizziNaples$333K
- Ramon Cuevas-TrisanRiviera Beach$220K
- Navdeep JassalLakeland$163K
- Mark-Friedrich HurdleJacksonville$140K
- Rodolfo GariTampa$120K
- Stephen PylesOcala$115K
- Orlando FloreteJacksonville$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.